Phreesia, Inc. (NYSE:PHR) General Counsel Sells $60,961.50 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 2,622 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $23.25, for a total transaction of $60,961.50. Following the sale, the general counsel now directly owns 123,075 shares of the company’s stock, valued at approximately $2,861,493.75. The sale was disclosed in a filing with the SEC, which is available at this link.

Phreesia Price Performance

Phreesia stock opened at $23.76 on Friday. The company’s 50 day simple moving average is $23.63 and its 200-day simple moving average is $22.75. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77. Phreesia, Inc. has a 1 year low of $12.05 and a 1 year high of $29.16.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Robert W. Baird raised their target price on Phreesia from $31.00 to $34.00 and gave the stock an “outperform” rating in a research note on Friday, September 6th. Truist Financial lifted their price target on Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a report on Friday, September 6th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research note on Thursday, September 5th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $29.42.

Institutional Trading of Phreesia

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Select Equity Group L.P. boosted its holdings in Phreesia by 14.7% during the 2nd quarter. Select Equity Group L.P. now owns 15,858 shares of the company’s stock valued at $336,000 after acquiring an additional 2,028 shares during the period. Deerfield Management Company L.P. Series C purchased a new position in shares of Phreesia in the second quarter valued at approximately $4,078,000. Squarepoint Ops LLC boosted its stake in shares of Phreesia by 56.3% in the second quarter. Squarepoint Ops LLC now owns 250,396 shares of the company’s stock valued at $5,308,000 after purchasing an additional 90,215 shares during the period. Point72 DIFC Ltd acquired a new position in shares of Phreesia in the second quarter valued at approximately $209,000. Finally, Lombard Odier Asset Management USA Corp purchased a new stake in Phreesia during the 2nd quarter worth approximately $202,000. Hedge funds and other institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.